Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Performance of the Delta System in the Treatment of Vasospasm in Aneurysmal Subarachnoid Hemorrhage (aSAH) Patients

NCT02129413 is registered in ClinicalTrials.gov with Samson NeuroSciences as lead sponsor.

NCT NCT02129413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02129413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Performance of the Delta System in the Treatment of Vasospasm in Aneurysmal Subarachnoid Hemorrhage (aSAH) Patients
Lead sponsor
Samson NeuroSciences
Phase
Not applicable
Overall status
Unknown status
Start date
May 31, 2014
Completion date
Not reported
Enrollment
23 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

aneurysmal subarachnoid hemorrhage, cerebral vasospasm